PCSK9 Forum
Click here to forward this email to a colleague
Facebook Twitter RSS YouTube linkedin
Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact
IN CASE YOU MISSED IT:
Slide resources from the PCSK9 Forum Expert Editorial Board - PCSK9 inhibition beyond monoclonal antibodies

Educational resources are an essential component of the mission of PCSK9 Forum to increase awareness and understanding of PCSK9 science and therapeutics.

PCSK9 Forum has recently launched a series of educational slide decks analysing key results from important trials with monoclonal antibodies to inhibit PCSK9. In the next series of slide decks, the focus is on an alternative approach to PCSK9 inhibition: inclisiran, a small interfering RNA therapeutic that specifically inhibits intracellular PCSK9 synthesis in hepatocytes.

Fourier

This deck discusses current approaches to PCSK9 inhibition and how inclisiran differs.

Odyssey

This deck will bring clinicians up to date with results from phase II/III trials in the ORION program with inclisiran.

View the first ORION slide deck »

View the second ORION slide deck »

Check here to review these unique educational resources – and don’t forget to bookmark this page for updates to this programme.


Like us on Facebook
For the latest updates, PCSK9 news and analysis.
Follow us on Twitter
Hot topics, news and conference reports.
YouTube Channel
For videos, interviews and webcasts from leading experts.
Don't miss our other slide decks focusing on key results and expert analysis from FOURIER, ODYSSEY OUTCOMES and ODYSSEY trials


DOWNLOAD THEM NOW »

Register now at www.pcsk9forum.org to access our new slide deck programme.
PCSK9 App

Educational Partners
and Supporters
Amgen The Medicines Company Sanofi
Copyright PCSK9 Forum 2020. Please click here to unsubscribe from future mailings.